Skip to main content
logo
Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
12.70
-0.71 (-5.29%)
At close: Mar 13, 2026, 4:00 PM EDT
12.53
-0.17 (-1.34%)
After-hours: Mar 13, 2026, 5:51 PM EDT

Enanta Pharmaceuticals Revenue

Enanta Pharmaceuticals had revenue of $18.62M in the quarter ending December 31, 2025, with 9.76% growth. This brings the company's revenue in the last twelve months to $66.98M, up 0.58% year-over-year. In the fiscal year ending September 30, 2025, Enanta Pharmaceuticals had annual revenue of $65.32M, down -3.42%.

Revenue (ttm)
$66.98M
Revenue Growth
+0.58%
P/S Ratio
5.50
Revenue / Employee
$558,167
Employees
120
Market Cap
368.55M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202565.32M-2.31M-3.42%
Sep 30, 202467.64M-11.57M-14.61%
Sep 30, 202379.20M-6.96M-8.07%
Sep 30, 202286.16M-10.91M-11.24%
Sep 30, 202197.07M-25.40M-20.74%
Sep 30, 2020122.47M-82.72M-40.31%
Sep 30, 2019205.20M-1.43M-0.69%
Sep 30, 2018206.63M103.81M100.97%
Sep 30, 2017102.81M14.55M16.48%
Sep 30, 201688.27M-72.61M-45.13%
Sep 30, 2015160.88M113.14M236.98%
Sep 30, 201447.74M15.69M48.94%
Sep 30, 201332.05M-9.65M-23.15%
Sep 30, 201241.71M-176.00K-0.42%
Sep 30, 201141.88M19.12M83.99%
Sep 30, 201022.76M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ginkgo Bioworks Holdings170.16M
Sutro Biopharma105.65M
Autolus Therapeutics51.13M
Lineage Cell Therapeutics14.56M
Crescent Biopharma10.84M
PureTech Health6.39M
Immutep5.28M
Armata Pharmaceuticals5.05M
Revenue Rankings

ENTA News

More News